There is an urgent need to address the global mortality of the COVID-19 pandemic, as it reached 6.3 million as of July 2022.As such, the experts recommended the mass diagnosis of SARS-CoV-2 infection at an early stage using nanotechnology-based sensitive diagnostic approaches.
The development of nanobiosensors for Point-of-Care (POC) sampling of COVID-19 could ensure mass detection without the fox farms ocean forest ph need for sophisticated laboratories or expert personnel.The use of Artificial Intelligence (AI) techniques for POC detection was also proposed.In addition, the utilization of various antiviral nanomaterials such as Silver Nanoparticles (AgNPs) for the development of masks for personal q60 headers protection mitigates viral transmission.
Nowadays, nano-assisted vaccines have been approved for emergency use, but their safety and effectiveness in the mutant strain of the SARS-CoV-2 virus remain challenging.Methodology: Updated literature was sourced from various research indexing databases such as PubMed, SCOPUS, Science Direct, Research Gate and Google Scholars.Result: We presented the concept of novel nanotechnology researched discovery, including nano-devices, electrochemical biosensing, nano-assisted vaccine, and nanomedicines, for use in recent times, which could be a formidable step for future management of COVID-19.